HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients

Overview of attention for article published in Frontiers in immunology, December 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 12 X users

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 75 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 254,819 followers.

@DerDrPappa @CarstenWatzl Hier noch zur Kreuzimmunität https://t.co/9T3y2qE2yq

08 Feb 2022

Reply Repost Favourite

Our data provides further evidence for frequent pre-existing T cells reactive against SARS-CoV-2 in unexposed healthy individuals (UHC). Cross-reactive T cells to peptide of SARS-CoV-2 in UHC was already reported by different groups ranging from 35% - 90%

31 May 2021

Reply Repost Favourite

RT @vmcorman: Congrats Sophie! HCoV- and SARS-CoV-2 cross-reactive T Cells in CVID patients. @ChariteBerlin #ChariteVirology https://t.co/v…

24 Dec 2020

Reply Repost Favourite

RT @vmcorman: Congrats Sophie! HCoV- and SARS-CoV-2 cross-reactive T Cells in CVID patients. @ChariteBerlin #ChariteVirology https://t.co/v…

23 Dec 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.